9/16/2009

Bristol-Myers Squibb will sell its over-the-counter drug assets in Asia and a 97.97% stake in its Indonesian unit to Japan's Taisho Pharmaceutical. The sale will allow Bristol-Myers to concentrate on its prescription-drug operations.

Related Summaries